Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

The primary objective of this protocol was to evaluate the degree to which a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment was usual (TAU) without STAGE-12 among stimulant abusers. For this protocol, STAGE-12 will be integrated into treatment as usual. This was a randomized, 2-group design comparing STAGE-12 integrated into TAU (STAGE-12 /TAU) to TAU without STAGE-12 for stimulant abusers receiving formal substance abuse treatment in participating community-based treatment programs (CTP). A total of approximately 450 stimulant users were recruited from 10 CTPS.

CTN Protocol ID: 
CTN-0031
DSMB ID: 
DSMB-0031
ClinicalTrials.gov ID: 

Principal Investigator(s)

Dennis M. Donovan, Ph.D.
Director
University of Washington
Department of Psychiatry and Behavioral Sciences
Alcohol and Drug Abuse Institute
1107 N.E. 45th Street, Suite 120
Box 354805
Seattle, WA 98105
ddonovan@u.washington.edu

Participating Sites